Typicality: | 0.527 |
Saliency: | 0.422 |
on normal cells | 15 | transitive-object |
on body weight | 9 | other |
on patients with advanced prostate cancer | 8 | transitive-object |
drug → have → little effect | 64 |
drug → have → little impact | 4 |
drug → have → little activity | 3 |
negative | neutral | positive |
0.361 | 0.486 | 0.154 |
Raw frequency | 71 |
Normalized frequency | 0.422 |
Modifier score | 0.800 |
Perplexity | 68.070 |